Home Site Map Search Members Only Contact Us
Home arrow About Us arrow Investigators
Investigators

Jane Buxton

Richard Harrigan

Robert Hogg

David Marsh

Julio Montaner  

Anita Palepu

David Patrick

Tim Rhodes

Kate Shannon

Jeannie Shoveller

Steffanie Strathdee

Mark Tyndall

 

 

 

 

 

Jane Buxton, MBBS, MHSc, FRCPC, conducts research in the areas of communicable disease control and the investigation of outbreaks. She also has a particular focus on hepatitis A, B, and C and the epidemiology of illicit drug use. Dr. Buxton is an Associate Professor in the School of Population & Public Health at the University of British Columbia. She is also a physician epidemiologist at the BC Centre for Disease Control. Her current research projects include an investigation of HIV and hepatitis C prevalence at three BC corrections facilities, as well as an investigation of issues concerning access to treatment for persons with hepatitis C. Dr. Buxton is the recipient of the BC Provincial Health Officer's “Award for Excellence in Public Health” for her commitment to knowledge generation and translation.

P. Richard Harrigan, PhD, has been involved in HIV research since 1992 and his research has focused on HIV drug efficacy and resistance, including the genetic basis of HIV drug resistance. At the BC Centre for Excellence, this has involved studies of more than 6,000 people in several major cohorts as well as in the Centre's Drug Treatment Program. In addition to directing clinically driven basic research initiatives, Dr. Harrigan has developed and implemented the HIV/AIDS Drug Resistance Testing Program and has initiated the development of a therapeutic drug and toxicity monitoring program which is currently under evaluation. Dr. Harrigan has previous experience in antiretroviral drug development and genomics research in the pharmaceutical industry. His work includes a significant contribution to the scientific literature, including descriptions of novel HIV drug resistance mutations and their effects on viral suppression and clinical outcomes, the impact of cross resistance, and recommendations for standards in drug resistance testing.

Robert S. Hogg, PhD, has established a national and international reputation in population health research with emphasis on HIV/AIDS, antiretroviral therapy, and marginalized populations. He has published extensively and received support from the National Health Research Development Program, Canadian Institutes of Health Research, and Michael Smith Foundation for Health Research. At the University of British Columbia, Dr. Hogg held the Michael O'Shaughnessy Chair in Population Health. He is currently an Adjunct Professor in the Department of International Health and Cross-Cultural Medicine at the University of California, San Diego, the Director of the HIV/AIDS Drug Treatment Program at the BC Centre for Excellence in HIV/AIDS, and a Professor in the Faculty of Health Science at Simon Fraser University.

David C. Marsh, MD, CCSAM, graduated in Medicine from Memorial University of Newfoundland in 1992, following prior training in neuroscience and pharmacology. In January 2004, Dr. Marsh began serving as the Physician Leader, Addiction Medicine with Vancouver Coastal Health and Providence Health Care. In this role he is also Medical Director for Addiction Services, HIV/AIDS Services and Aboriginal Health for Vancouver Community. Dr. Marsh is also Clinical Associate Professor in the Department of Health Care and Epidemiology, Faculty of Medicine at the University of British Columbia. In 2004 Dr. Marsh received the Nyswander-Dole Award from the American Association for the Treatment of Opioid Dependence in recognition of his contribution to this field.

Julio S. G. Montaner, MD, FRCPC, FCCP, is the Director of the BC Centre for Excellence in HIV/AIDS and Professor of Medicine and Chair of AIDS Research at the University of British Columbia. Dr. Montaner is also the President of the International AIDS Society (IAS) and a member of the Antiretroviral Therapy Guidelines Committee of the IAS-USA. He has published more than 300 scientific papers in international peer-reviewed journals.

Anita Palepu, MD, MPH, FRCPC, is an Associate Professor, Division of Internal Medicine at the University of British Columbia and conducts research at the Centre for Health Evaluation and Outcome Sciences and the BC Centre for Excellence in HIV/AIDS. Her research program falls under the broad umbrella of urban health research, with particular interest in vulnerable populations such as drug users, HIV-infected persons, and homeless persons. She has collaborated with researchers at Boston University to study the effect of substance abuse treatment on health care utilization, antiretroviral therapy uptake and adherence among HIV-infected persons with alcohol problems. She is also part of a network of Canadian researchers examining issues pertaining to housing, homelessness and health. In 2004, she assumed co-directorship of the UBC Department of Medicine's Clinical Investigator Program and was honoured with a Michael Smith Foundation for Health Research Senior Scholar Award. As an internal medicine specialist at St. Paul's Hospital, Dr. Palepu is active in teaching residents and medical students. In March 2006 she resigned as Associate Scientific Editor with the Canadian Medical Association Journal on the grounds of editorial interference by the CMA and since then has been actively involved with the launch of Open Medicine, a peer-reviewed, independent, open-access journal. She was also Conference Chair of the 7th International Conference on Urban Health, held in Vancouver October 29-31, 2008.

David M. Patrick, MD, MHSc, FRCPC, is Professor of Medicine and Director of the School of Population & Public Health at the University of British Columbia. His interest is in fostering interdisciplinary approaches to the control of infectious diseases in populations. Current expressions of this focus are found in the application of epidemiological measurement to evaluating control efforts against resistant organisms and the establishment of interdisciplinary efforts to understand the emergence of new infectious diseases.

Tim Rhodes, BSc, MSc, PhD, leads a program of research focused on the social aspects of drug use and drug-related health harm at the London School of Hygiene and Tropical Medicine, University of London . He has been leading research projects in HIV/HCV risk and prevention associated with injecting drug use in Russia and South Eastern Europe, and has undertaken consultancy for DFID, WHO, UNAIDS and UNICEF. He leads the Centre for Research on Drugs and Health Behaviour and is editor of the International Journal of Drug Policy . His current research includes a qualitative study of HIV treatment access and experience among people living with HIV in Serbia and Montenegro; a qualitative prospective study of narratives of risk and hope among people living with HIV; a qualitative study of crack and speedball injection and visual assessment of injecting drug use; and multi-method studies of HIV/HCV prevalence and risk environment among injecting drug users and sex workers in Serbia, Montenegro, and Russia. Current research interests include social and structural factors shaping drug-related health harm and the role of environmental interventions.

Kate Shannon, PhD, is an Assistant Professor in the Department of Medicine, Division of AIDS, at the University of British Columbia and a Research Scientist with the British Columbia Centre for Excellence in HIV/AIDS. Prior to coming to Vancouver, Dr. Shannon received a masters of public health degree in global health from Australia while working on maternal and reproductive health projects in rural Bangladesh and Nepal. She is a social and infectious disease epidemiologist with extensive experience in social and structural contexts of sexual health and HIV/STI transmission dynamics. She currently leads HIV/STI prevention research with street-involved women who use drugs and exchange sex in Vancouver, and is also consulting on gendered HIV/STI interventions and female sex work projects in India, US-Mexico border cities, and sub-Saharan Africa. Dr. Shannon has received a number of awards, including the New Investigator Award in the Epidemiology and Public Health Track in 2007 at the Canadian Association for HIV/AIDS Research conference and the Bisby Award in 2008 as the top-ranked Fellow in the Canadian Institutes of Health Research’s biannual competition.

Jeannie Shoveller, PhD, is a leading researcher focusing on the social and institutional contexts of youth health, with a particular emphasis on investigating the impact of gender, culture and place on sexual health disparities among young people. She is currently the principal investigator on a five-year, CIHR Interdisciplinary Capacity Enhancement Team Grant to investigate sexual health disparities among rural and northern youth. She is also the principal investigator on two additional CIHR-funded studies: an investigation of the impact of sex, gender and place on youth's experiences with STI testing; and a participatory action research project to develop new approaches to engage rural and northern youth in social determinants analyses of sexual health outcomes. In addition to her research in Canadian settings, she works with colleagues in Brazil and Canada on a multi-site project to reduce inequalities in the peripheries of five major metropolitan areas in Brazil. Through intersectoral and inter-jurisdictional cooperation, the Brazil-Canada team (led jointly by Brazil 's Ministry of Cities and UBC) are contributing to the development of novel mechanisms for addressing the needs of people living in informal settlements who are experiencing social and spatial exclusion in highly urbanized settings.

Steffanie A. Strathdee, PhD, is an infectious disease epidemiologist who has spent the last two decades focusing on underserved, marginalized populations in developed and developing countries. Since January 2004, she has been the Harold Simon Chair and Chief of the Division of International Health and Cross Cultural Medicine in the Department of Family and Preventive Medicine at the University of California San Diego School of Medicine. She is also an Adjunct Professor at Johns Hopkins University. Her recent work has focused on the prevention of blood-borne infections, specifically HIV and viral hepatitis, and barriers to care among injection drug using populations. In the last decade, she has authored more than 200 peer-reviewed publications on HIV prevention and the natural history of HIV infection. She is the principal investigator of several behavioural intervention studies among drug users, and has played a leading role in evaluations of needle exchange programs in Canada and the United States. Currently, she is engaged in research projects in a number of international settings, including Mexico, Brazil, Canada, Pakistan, India, Tajikistan and Russia. She leads a cross-border HIV prevention training program as a TIES partnership between UCSD, San Diego State University, El Colegio de la Frontera Norte and Universidad Autonoma de Baja California at Tijuana.

Mark W. Tyndall, MD, ScD, FRCPC, is the Program Director, Epidemiology, at the BC Centre for Excellence in HIV/AIDS. He is an Associate Professor in the Department of Medicine at the University of British Columbia and Head of the Infectious Diseases Division at Providence Health Care. He has national and international research expertise in the area of clinical epidemiology, sexually transmitted infections, HIV/AIDS prevention and harm reduction, and HIV and hepatitis C treatment among marginalized populations. Dr. Tyndall has published more than 120 scientific papers and is a Michael Smith Foundation for Health Research Senior Scholar.